← Back to Clinical Trials
Recruiting NCT06397469

NCT06397469 Enhancing Attention and Wellbeing Using Digital Therapeutics

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06397469
Status Recruiting
Phase
Sponsor University of California, San Francisco
Condition Aging
Study Type INTERVENTIONAL
Enrollment 4,000 participants
Start Date 2024-04-01
Primary Completion 2029-01

Trial Parameters

Condition Aging
Sponsor University of California, San Francisco
Study Type INTERVENTIONAL
Phase N/A
Enrollment 4,000
Sex ALL
Min Age 60 Years
Max Age 99 Years
Start Date 2024-04-01
Completion 2029-01
Interventions
MediTrainWorder

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.

Eligibility Criteria

Inclusion Criteria: * 60+ years old (adult) * English language fluency * owning a smartphone or tablet Exclusion Criteria: * Under 60 years old (minor)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology